Decadal mean regional hydrology. by Nic Gedney (19762301)

Simulated regional mean wetland seasons. by Nic Gedney (19762301)

Contemporary mean inundation fraction in the Amazon basin. by Nic Gedney (19762301)

Regional contemporary (1990–1999 mean) precipitation and JULES inundation fraction over the Amazon basin. by Nic Gedney (19762301)

Percentage regional changes in decadal regional hydrology. by Nic Gedney (19762301)

Projected decadal changes in seasonality in the hydrological cycle over the wetland regions. by Nic Gedney (19762301)

Wetland classification scheme for the contemporary period. by Nic Gedney (19762301)

Decadal seasonality of the hydrological cycle over the wetland regions. by Nic Gedney (19762301)

Overall analysis of randomized controlled trials. by Solima Sabeel (9545738)

“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”

Newcastle-Ottawa scale. by Solima Sabeel (9545738)

“…Notably, atorvastatin demonstrated the most significant reduction in IL-6 and TNF-α levels, while fluvastatin and rosuvastatin displayed the greatest impact on decreasing CRP and LDL-C levels, respectively. …”

Data Sheet 1_Comparative efficacy and safety of antidiabetic agents for post-transplant diabetes mellitus: a network meta-analysis.docx by Shanbiao Hu (15063765)

“…Compared to placebo, insulin produced the greatest reductions in HbA1c (mean difference [MD] − 0.35, 95% CI − 0.90 to 0.20) and FPG (MD − 9.06 mmol/L, 95% CI − 18.66 to 0.53). …”

Data Sheet 1_Does chlorhexidine improve periodontal health and bacterial profiles in patients with special health care needs? A systematic review and meta-analysis.docx by Deepak Sharma (131639)

“…CHX use was associated with a statistically significant reduction in plaque accumulation (Hedges' g = −1.491; 95% CI: −2.067 to −0.914; P < .001; I² = 37.3%), with the greatest reductions observed in studies using spray and gel delivery methods. …”

Data Sheet 1_Efgartigimod for generalized myasthenia gravis in the extreme elderly (≥80 years): a multicenter retrospective real-world study.pdf by Ye Hong (2580841)

“…At week 4 (1week after the final infusion), the study showed significant reductions in all efficacy measurements: MG-ADL scores decreased by 52.2% ± 30.8% (from 10.9 ± 2.7 to 3.6 ± 2.1), QMG scores by 36.6% ± 28.4% (from 18.2 ± 7.0 to 11.7 ± 8.3), MGC scores by 48.2% ± 33.4% (from 17.8 ± 7.5 to 9.0 ± 8.6). …”